Apyx Medical Analyst Ratings
Apyx Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | -10.45% | Piper Sandler | $4 → $4.5 | Maintains | Overweight |
| 07/14/2023 | 59.2% | Stephens & Co. | → $8 | Initiates Coverage On | → Overweight |
| 06/15/2023 | 79.1% | Lake Street | $6 → $9 | Maintains | Buy |
| 05/24/2023 | — | JMP Securities | Reiterates | → Market Perform | |
| 05/12/2023 | 19.4% | Lake Street | $5 → $6 | Maintains | Buy |
| 12/08/2022 | -0.5% | Lake Street | → $5 | Assumes | → Buy |
| 08/12/2022 | 138.81% | Piper Sandler | $6 → $12 | Maintains | Overweight |
| 07/19/2022 | 238.31% | Lake Street | $14 → $17 | Maintains | Buy |
| 05/20/2022 | 138.81% | Lake Street | → $12 | Initiates Coverage On | → Buy |
| 08/13/2021 | 178.61% | JMP Securities | $12 → $14 | Maintains | Market Outperform |
| 05/12/2020 | -0.5% | JMP Securities | $7 → $5 | Maintains | Market Outperform |
| 11/12/2019 | 99% | Piper Sandler | $8 → $10 | Maintains | Overweight |
| 04/02/2019 | 59.2% | JMP Securities | $12 → $8 | Maintains | Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/11/2023 | -10.45% | 派珀·桑德勒 | 4 美元 → 4.5 美元 | 維護 | 超重 |
| 07/14/2023 | 59.2% | Stephens & Co. | → 8 美元 | 啓動覆蓋開啓 | → 超重 |
| 06/15/2023 | 79.1% | 湖街 | 6 美元 → 9 美元 | 維護 | 購買 |
| 05/24/2023 | — | JMP 證券 | 重申 | → 市場表現 | |
| 05/12/2023 | 19.4% | 湖街 | 5 美元 → 6 美元 | 維護 | 購買 |
| 2022 年 8 月 12 日 | -0.5% | 湖街 | → 5 美元 | 假設 | → 購買 |
| 2022 年 12 月 8 日 | 138.81% | 派珀·桑德勒 | 6 美元 → 12 美元 | 維護 | 超重 |
| 2022 年 7 月 19 日 | 238.31% | 湖街 | 14 美元 → 17 美元 | 維護 | 購買 |
| 05/20/2022 | 138.81% | 湖街 | → 12 美元 | 啓動覆蓋開啓 | → 購買 |
| 08/13/2021 | 178.61% | JMP 證券 | 12 美元 → 14 美元 | 維護 | 市場表現跑贏大盤 |
| 05/12/2020 | -0.5% | JMP 證券 | 7 美元 → 5 美元 | 維護 | 市場表現跑贏大盤 |
| 2019 年 12 月 11 日 | 99% | 派珀·桑德勒 | 8 美元 → 10 美元 | 維護 | 超重 |
| 2019 年 2 月 4 日 | 59.2% | JMP 證券 | 12 美元 → 8 美元 | 維護 | 市場表現跑贏大盤 |
What is the target price for Apyx Medical (APYX)?
Apyx Medical（APYX）的目標價格是多少？
The latest price target for Apyx Medical (NASDAQ: APYX) was reported by Piper Sandler on August 11, 2023. The analyst firm set a price target for $4.50 expecting APYX to fall to within 12 months (a possible -10.45% downside). 7 analyst firms have reported ratings in the last year.
派珀·桑德勒於2023年8月11日公佈了Apyx Medical（納斯達克股票代碼：APYX）的最新目標股價。這家分析公司將目標股價定爲4.50美元，預計APYX將在12個月內跌至12個月內（可能下跌-10.45％）。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Apyx Medical (APYX)?
分析師對Apyx Medical（APYX）的最新評級是多少？
The latest analyst rating for Apyx Medical (NASDAQ: APYX) was provided by Piper Sandler, and Apyx Medical maintained their overweight rating.
Apyx Medical（納斯達克股票代碼：APYX）的最新分析師評級由派珀·桑德勒提供，Apyx Medical維持其增持評級。
When is the next analyst rating going to be posted or updated for Apyx Medical (APYX)?
Apyx Medical（APYX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apyx Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apyx Medical was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Apyx Medical的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Apyx Medical的最後一次評級是在2023年8月11日提交的，因此您應該預計下一個評級將在2024年8月11日左右公佈。
Is the Analyst Rating Apyx Medical (APYX) correct?
分析師對Apyx Medical（APYX）的評級正確嗎？
While ratings are subjective and will change, the latest Apyx Medical (APYX) rating was a maintained with a price target of $4.00 to $4.50. The current price Apyx Medical (APYX) is trading at is $5.03, which is out of the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Apyx Medical（APYX）評級維持不變，目標股價爲4.00美元至4.50美元。Apyx Medical（APYX）目前的交易價格爲5.03美元，超出了分析師的預測區間。